At a glance
- Originator Nonindustrial source
- Class Antidepressants; Anxiolytics; Peptides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 11 Feb 2002 No-Development-Reported for Anxiety disorders in USA (Unknown route)
- 30 May 2001 Profile reviewed but no significant changes made
- 25 Aug 1998 No-Development-Reported for Anxiety disorders (Unknown route)